Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
British Journal of Haematology
|
July 10, 2001
Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method
A H Elmaagacli, A Freist, M Hahn, et al.
Acta Haematologica
|
November 11, 2006
Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia
L Eisele, L Klein-Hitpass, N Chatzimanolis, et al.
Blood
|
May 15, 1995
Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome
D W Beelen, U Graeven, A H Elmaagacli, et al.
Bone Marrow Transplantation
|
December 1, 1995
Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia
A H Elmaagacli, H W Becks, D W Beelen, et al.
Bone Marrow Transplantation
|
November 18, 2000
Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II study
D W Beelen, R Peceny, A Elmaagacli, et al.
Cytogenetics and Cell Genetics
|
August 18, 1999
Assignment of human filamin gene FLNB to human chromosome band 3p14.3 and identification of YACs containing the complete FLNB transcribed region
F Bröcker, W Bardenheuer, L Vieten, et al.
Journal of Cancer Research and Clinical Oncology
|
August 10, 2000
Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene
M Flasshove, W Bardenheuer, A Schneider, et al.
Bone Marrow Transplantation
|
July 31, 2001
A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase
A H Elmaagacli, K Runkel, N Steckel, et al.
Acta Haematologica
|
January 1, 1994
Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remission
L Diekmann, D W Beelen, K Quabeck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patients
N Niederle, T Moritz, O Kloke, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
British Journal of Haematology
|
July 10, 2001
Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method
A H Elmaagacli, A Freist, M Hahn, et al.
Acta Haematologica
|
November 11, 2006
Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia
L Eisele, L Klein-Hitpass, N Chatzimanolis, et al.
Blood
|
May 15, 1995
Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome
D W Beelen, U Graeven, A H Elmaagacli, et al.
Bone Marrow Transplantation
|
December 1, 1995
Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia
A H Elmaagacli, H W Becks, D W Beelen, et al.
Bone Marrow Transplantation
|
November 18, 2000
Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II study
D W Beelen, R Peceny, A Elmaagacli, et al.
Cytogenetics and Cell Genetics
|
August 18, 1999
Assignment of human filamin gene FLNB to human chromosome band 3p14.3 and identification of YACs containing the complete FLNB transcribed region
F Bröcker, W Bardenheuer, L Vieten, et al.
Journal of Cancer Research and Clinical Oncology
|
August 10, 2000
Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene
M Flasshove, W Bardenheuer, A Schneider, et al.
Bone Marrow Transplantation
|
July 31, 2001
A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase
A H Elmaagacli, K Runkel, N Steckel, et al.
Acta Haematologica
|
January 1, 1994
Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remission
L Diekmann, D W Beelen, K Quabeck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patients
N Niederle, T Moritz, O Kloke, et al.
Page
of 7